Task: Answer the following question about the molecule with SMILES CNNCc1ccc(C(=O)NC(C)C)cc1.Cl.
Question: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Result: Approved
Task: Answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CNNCc1ccc(C(=O)NC(C)C)cc1.Cl
CNNCc1ccc(C(=O)NC(C)C)cc1.Cl
4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide;hydrochloride
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.